AbbVie has announced its participation in the upcoming Leerink Partners Global Healthcare Conference. The event is scheduled for Tuesday, March 11, 2025, where the company's management will engage in a fireside chat at 7:40 a.m. Central time.
The company has made provisions for a live audio webcast of the presentation, which will be available on AbbVie's Investor Relations website at investors.abbvie.com. Additionally, an archived version of the session will be accessible later that same day.
AbbVie emphasizes its mission to "discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow." The company focuses on various therapeutic areas including immunology, oncology, neuroscience, and eye care. It also offers products and services within its Allergan Aesthetics portfolio.
For further information about AbbVie or to follow their updates on social media platforms like LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube, individuals can visit www.abbvie.com.
Media inquiries can be directed to Gabby Tarbert at (224) 244-0111 or via email at gabrielle.tarbert@abbvie.com. Investors may contact Liz Shea at (847) 935-2211 or liz.shea@abbvie.com.